Journal of Commercial Biotechnology — July 2008
15. Jul, 2008 
1 Comment
The March 2008 issue of the Journal of Commercial Biotechnology is now available. This issue focuses on biotechnology marketing and was guest-edited by Leyland Pitt and Ian McCarthy. The links below will take you to the abstract of each article:
Volume 14, Issue 3
Editorial
Leyland Pitt and Ian McCarthy
New pharmaceutical product development: Barriers to overcome and opportunities to exploit
Nic S Terblanche
The biotechnology and marketing interface: Functional integration using mechanistic and holographic responses to environmental turbulence
Pierre Berthon, Leyland Pitt, Deon Nel, Esmail Salehi-Sangari and Anne Engstrom
Anticipating and managing the challenges of biotechnology marketing
Heidi Rajamäki
A comparison of R&D indicators for the Vancouver biotechnology cluster
Monica Salazar, Martin J Bliemel and J Adam Holbrook
Using brand personality to assess whether biotechnology firms are saying the right things to their network
Lisa Papania, Colin Campbell, Robert Ankomah Opoku, Maria Styven and Jean-Paul Berthon
Remembering Epimetheus: Biotechnologies and the market
Pierre Berthon, Ekin Pehlivan and Philip DesAutels
Networks of dedicated biotechnology and service firms in Vancouver
Martin J Bliemel and Ian P McCarthy
The Journal of Commercial Biotechnology is online at http://www.palgrave-journals.com/jcb.
I want to quote your post in my blog. It can?
And you et an account on Twitter?